ABBOTT LABORATORIES A/S: Financial statements 2025
CVR: 31528615
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ABBOTT LABORATORIES A/S (CVR 31528615) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 412,831,732 and a net result of DKK 63,142,932 compared with DKK 8,276,415 the year before. That is an increase of 17.8% compared with the year before. The profit margin was 15.3%. Equity in the 2025 report amounted to DKK 74,374,860. The solvency ratio was 37.6%. The company had 48 employees in the financial year.
- Revenue
- DKK 412,831,732
- Gross Profit
- DKK 66,799,196
- Profit/Loss
- DKK 63,142,932
- Equity
- DKK 74,374,860
- Total Assets
- DKK 197,808,726
- Employees
- 48
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 412.8 mio. | 66.8 mio. | 63.1 mio. | 74.4 mio. | 48 |
| 2024 | 350.4 mio. | 63.6 mio. | 8.3 mio. | 141.2 mio. | 49 |
| 2023 | 327.4 mio. | 62.6 mio. | 9.2 mio. | 133 mio. | 50 |
| 2022 | 268.1 mio. | 51.2 mio. | 6.1 mio. | 123.8 mio. | 44 |
| 2021 | 259.2 mio. | 44.2 mio. | 6 mio. | 117.7 mio. | 39 |
Official annual report
How creditworthy is ABBOTT LABORATORIES A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ABBOTT LABORATORIES A/S has published its annual report for 2024. Revenue came to DKK 350,376,814, and the net result was DKK 8,276,415.
About ABBOTT LABORATORIES A/S
ABBOTT LABORATORIES A/S is a Danish company of the type Aktieselskab based in København S, founded in 1971. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Karl Andreas Almroth. The board consists of Bradley Jay Slater (chair), Fredrik Björn Anders Björnulfson and Karl Andreas Almroth. The company is owned by ABBOTT MEDICAL OVERSEAS CYPRUS LIMITED. The company has 48 employees (2026). In 2025, the company reported revenue of DKK 412,831,732 and a net result of DKK 63,142,932 compared with DKK 8,276,415 the year before. Equity in the 2025 report amounted to DKK 74,374,860.